Loading clinical trials...

Cohorte Nationale VIH-2 | Clinical Trials | Clareo Health

UNKNOWNNCT04658329

Cohorte Nationale VIH-2

The HIV2 study is an open cohort of prospective, multicentric, national observation. The main objective is to study HIV-2 infection in adult patients followed in France.

Lead sponsor: ANRS, Emerging Infectious Diseases•29 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Sophie Matheron, Pr, MD

CONTACT

01 40 25 72 39 [email protected]

Julie Longobardi

CONTACT

05 57 57 48 12 [email protected]

Related studies

COMPLETEDPhase 2

Trial Evaluating a First Line Combination Therapy With Raltegravir, Emtricitabine and Tenofovir in HIV-2 Infected Patients

NCT01605890 · HIV-2 Infection

TERMINATEDNA

RESIST-2: 2nd-line ART for HIV-2 Infection

NCT03394196 · HIV-2 Infection

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 8, 2020Terms

Trial snapshot

StatusUNKNOWN

Phase—

Enrollment1,185

Start dateJan 1994

Last updatedDec 8, 2020

Condition

HIV-2 Infection

Locations shown

Centre hospitalier Victor Dupouy

Argenteuil

Avicenne

Bobigny

Hôpital Saint André

Bordeaux

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 8, 2020Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions